Concepedia

Anthony Doyle

AD

Statistics

Publications

17

Citations

1K

H-Index

14

Active since

1992

Affiliations

Teva Pharmaceuticals (Australia)(Current)

University of Oxford

Teva Pharmaceuticals (United States)

Holy Spirit Northside Private Hospital

The University of Queensland

Anthony Doyle is an author at Teva Pharmaceuticals (Australia) specializing in immunology, life sciences, and cytokine biology.

Publications per year

1992–2019

17

Publications

17

Interleukin‐13 alters the activation state of murine macrophages <i>in vitro</i>: Comparison with interleukin‐4 and interferon‐γ

Anthony Doyle, Georges Herbein, Luis J. Montaner et al. · European Journal of Immunology · 1994 · 307 citations

, , +15

Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function.

Willem J. de Villiers, Iain P. Fraser, Derralynn Hughes et al. · The Journal of Experimental Medicine · 1994 · 127 citations · Full text

, , +17

Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro.

L.J. Montaner, Anthony Doyle, Matthew Collin et al. · The Journal of Experimental Medicine · 1993 · 105 citations · Full text

, , +17

Single-cell analysis by RT-PCR reveals differential expression of multiple type 1 and 2 cytokine genes among cells within polarized CD4+ T cell populations

Anne Kelso, Penny Groves, Louise E. Ramm et al. · International Immunology · 1999 · 62 citations · Full text

, , +17

Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity

Sarah Pogue, Tetsuya Taura, Mingying Bi et al. · PLoS ONE · 2016 · 59 citations · Full text

, , +8

1–5 of 17